An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.
Investigational Drug Acquiring Popularity Online
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Viewers are encouraged to contact these profiles privately for source information, while also obtaining discount codes.
Active Commerce on Social Networks
Separately, a robust trade exists on Telegram, where groups with thousands of participants share comparison photos, administration instructions and assertions of rapid British shipping. Sellers market the substance there before redirecting customers to other platforms for purchases.
Understanding The Experimental Drug
This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Professionals Express Concerns
However, physicians and chemists have warned that the sale of what is still an unapproved medication in the UK is a cause for concern and could result in individuals injecting products of uncertain source.
Some professionals stated the popularity for the experimental drug could be linked to the rising price of licensed slimming products such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the British medical regulations.
Some influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate pharmaceutical, advertising, and customer regulations, potentially leading to penalties, prosecution or imprisonment.
Platform Response and Material Removal
Based on TikTok, the platform has taken down problematic content and banned related keywords and query recommendations. The company said it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.
Digital Trading Activities
Research also discovered communities with up to nine thousand participants selling the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of members, populated with images of slimming results, positive reviews and step-by-step guides for preparing or administering at home.
Within moments of entering one community, a vendor posted WhatsApp details, where most purchases take place. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about weight, medical conditions or previous experience.
Item Information and Pricing
Inside these groups, posts show dark colored parcels with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at residence with purified liquid, or pre-filled pens typically priced at 160 pounds for 20mg. When questioned how long a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.
Service Moderation and Safety Measures
A representative for the messaging service said it actively moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering substances they cannot confirm. Although the science behind this drug is sound, these digital products may not include what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service linked the surge in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.
Her team has previously seen individuals harmed by personal administration from unverified suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”
Producer Position
A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a company investigational product not yet approved … may subject patients to possibly serious health risks”.
